Startups
Edit

Continuous Glucose Monitoring (CGM)

https://www.freestyle.abbott/us-en/home.html
Last activity: 26.08.2026
Active
Check your blood glucose without fingersticks using the FreeStyle Libre System, a continuous glucose monitoring system that includes a sensor and reader.
Website visits
1.2M /mo.
Mentions
10

Mentions in press and media 10

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Jun 20, 2025Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus SensorWhat You Should Know: – Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s ...
Jun 19, 2025Continuous Glucose Monitoring Systems Market Size Set for Rapid Expansion, Valued at USD 31.70 billion by 2031Continuous Glucose Monitoring (CGM) Increase in the incidence of diabetes cases, high-end technological advancements, & the benefits of CGMS over POC glucometers drive the growth of market. PORTLAND, OR, UNITED STATES, June 19, 2025 /EI...
Aug 7, 2024Abbott and Medtronic Partner to Integrate CGM System & Insulin Delivery DevicesWhat You Should Know: – Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work with Medtronic’s automated insulin delivery (AID) and smart ...
Apr 12, 2024Continuous Glucose Monitoring Device Market Valued at USD 54,735.48 million by 2032, Growing at an Impressive 21.8% Compound Annual Growth RateContinuous Glucose Monitoring Device Market Valued at USD 54,735.48 million by 2032, Growing at an Impressive 21.8% Compound Annual Growth Rate 04-12-2024 11:25 AM CET | Health & Medicine Press release from: Polaris Market Research &...
Jul 24, 2023Recent Abbott Snafu Shines Spotlight on Social Media’s Role in Public Health Crisis ResponseSocial media should play a bigger part in public health crisis planning, according to a recent analysis from digital health consulting firm Creation Healthcare. The analysis explored the crucial role that Twitter and other social media plat...
Feb 28, 2022Rimidi to Showcase Continuous Glucose Monitor Integration with the EHR at ViVE, HIMSS 2022With unprecedented innovation in medical devices and sensors, patient care will require an ecosystem of devices and that data cannot live in separately-accessed disparate systems. ATLANTA (PRWEB) February 28, 2022 Rimidi, a leading clinical...
Feb 1, 2022Rimidi Achieves 72% Revenue Growth, Grows Client Base by 141% in 2021As health systems continued to feel the strain of COVID-19, our team at Rimidi worked directly with our customers to ensure they had the tools, solutions and services necessary to deliver better workflows, experiences and outcomes. ATLANTA ...
Feb 1, 2021Ray Allen Continuing To Advocate For Diabetes Research In Retirement
May 31, 2017Continuous Glucose Monitoring Systems Market Anticipated to be Valued at US$ 788.4 Mn by 2020Continuous Glucose Monitoring Systems Market Anticipated to be Valued at US$ 788.4 Mn by 2020 05-31-2017 08:02 AM CET | Advertising, Media Consulting, Marketing Research Press release from: Future Market Insights Future Market Insights (FMI...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Continuous Glucose Monitoring (CGM)

What has the press written about Continuous Glucose Monitoring (CGM)?

Parsers VC has collected 10 articles mentioning Continuous Glucose Monitoring (CGM), among them “Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus Sensor” (Jun 20, 2025) and “Continuous Glucose Monitoring Systems Market Size Set for Rapid Expansion, Valued at USD 31.70 billion by 2031” (Jun 19, 2025).

Is Continuous Glucose Monitoring (CGM) still active?

Yes, Continuous Glucose Monitoring (CGM) is active; its latest activity on Parsers VC dates from Aug 26, 2026.